Peter Kubisz

von Willebrand Factor, Soluble P-Selectin, Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Atherosclerosis

Andrew D. Blann, Miroslava Dobrotová, Peter Kubisz et al. · Thrombosis and Haemostasis · 1995 · 143 citations

Medicine, Cardiology, Hemostasis +13

Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow‐up study

Juraj Sokol, J.F. Timp, Saskia le Cessie et al. · Journal of Thrombosis and Haemostasis · 2018 · 39 citations · Full text

Medicine, Hematology, Internal Medicine +14

Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus

Peter Kubisz, Peter Chudý, Ján Staško et al. · Acta Diabetologica · 2009 · 37 citations

Medicine, Endocrinology, Internal Medicine +9

The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation

Tomáš Bolek, Matej Samoš, Lucia Stančiaková et al. · American Journal of Therapeutics · 2017 · 36 citations

Medicine, Pharmacology, Pharmacotherapy +17

The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria

Peter Chudý, Daniela Kotuličová, Ján Staško et al. · Blood Coagulation & Fibrinolysis · 2011 · 34 citations

Medicine, Internal Medicine, Diabetology +13